CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Back to all Representative Matters
Feb 4, 2021

Cybin Completes $34 Million Bought Deal Offering

Sherri M. Altshuler, Melanie Cole, Danny Kharazmi, Russell J. Sanders, Sean Green, Meredith McCann and Barbara Worndl

On February 4, 2021, Cybin Inc. (NEO: CYBN) (the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, completed a bought deal short form prospectus offering. In connection with the offering, the Company issued 15,246,000 units (“Units”) at a price of $2.25 per Unit for aggregate gross proceeds of $34,303,500. Each Unit consisted of one common share and one half of one common share purchase warrant of the Company.

Cybin intends to use the net proceeds from the offering to advance its clinical trials, novel molecule programs and technologies surrounding the patient experience, and for working capital and general corporate purposes.

Aird & Berlis acted for Cybin with a team that included Sherri Altshuler, Melanie Cole, Danny Kharazmi, Russell Sanders, Sean Green and Meredith McCann (Capital Markets/M&A) and Barbara Worndl (Tax).

Related Representative Matters

Representative Matters
Small Pharma Completes $63 Million Brokered and Non-Brokered Private Placements, Qualifying Transaction and Initial Listing on the TSX Venture Exchange Richard M. Kimel, Melanie Cole, Danny Kharazmi, Sean Green, Emily Chittick and Al Turnbull May 03, 2021 Aird & Berlis acted as Canadian legal counsel to Small Pharma with a team that included Richard K... Aird & Berlis acted as Canadian legal counsel to Small Pharma with a team that included Richard Kimel, Melanie Cole, Danny Kharazmi, Sean Green (Capital Markets), Emily Chittick and Al Turnbull (Articling S...
Representative Matters
PsyBio Completes Reverse Takeover and $14.5 Million Private Placement Sherri M. Altshuler, Melanie Cole, Adria Leung Lim, Amy Marcen-Gaudaur, Russell J. Sanders, Meredith McCann and Barbara Worndl Feb 19, 2021 Aird & Berlis represented PsyBio Therapeutics, Inc. in a reverse takeover transaction and $14.5 m... Aird & Berlis represented PsyBio Therapeutics, Inc. in a reverse takeover transaction and $14.5 million private placement.
Representative Matters
Harborside Inc. Completes $35 Million Private Placement Sherri M. Altshuler, Adria Leung Lim, Amy Marcen-Gaudaur and Meredith McCann Feb 18, 2021 Harborside Inc., a California-focused, vertically-integrated cannabis enterprise, recently comple... Harborside Inc., a California-focused, vertically-integrated cannabis enterprise, recently completed a brokered private placement offering of units for aggregate gross proceeds of approximately $35 million.